A company based just to Logan City’s north is one step closer to delivering an innovative point-of-care (PoC) rapid COVID-19 test.
Deputy Premier Steven Miles said $1.4 million funding will allow AnteoTech, a life science and nano-scale surface chemistry company, to progress its high-sensitivity and low-cost test from prototype through to manufacturing and product launch subject to successful clinical trials and regulatory approvals.
The project aims to finalise the development of a high-sensitivity COVID-19 Antigen Rapid Test (ART) which would deliver results in just 15 minutes.
On product launch, Anteotech will be set to produce a large volume of tests at its facility at Eight Mile Plains.
AnteoTech CEO Derek Thomson said funding for projects such as this would ensure Queensland remains at the forefront of a thriving and highly competitive industry.
“We are immensely proud to have made the decision to develop this test and accelerate our Assay Development business. We believe that through our technology and IP we can offer an exceptional product that can make a substantial contribution in the global fight against the COVID-19 virus,” Mr Thomson said.
